Development of WT1 Peptide Cancer Vaccine Against Hematopoietic Malignancies and Solid Cancers

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|20|2345-2352

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.20, 2006-08, pp. : 2345-2352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

“Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development

By  

Current Medicinal Chemistry, Vol. 15, Iss. 29, 2008-12 ,pp. : 3052-3061

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Cancer Vaccine Targeting WT1 Product which is Expressed in Various Kinds of Malignant Neoplasms

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 6, 2005-12 ,pp. : 447-454

Bentham Science Publishers

Access to resources Recommend Favorite

Harnessing Bioinformatics for Designing a Novel Multiepitope Peptide Vaccine Against Breast Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 12, 2016-10 ,pp. : 1100-1114

Bentham Science Publishers

Access to resources Recommend Favorite

Gemcitabine/WT1 peptide loaded dendritic cell vaccine: Injection site reactions in elderly patients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1335, 2011-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

Vaccine against cervical cancer

By  

Reproductive BioMedicine Online, Vol. 13, Iss. 6, 2006-12 ,pp. : 800-800

Reproductive Healthcare Ltd

Access to resources Recommend Favorite